Global Type 1 Diabetes Medicines Supply, Demand and Key Producers, 2024-2030

Description

Type 1 diabetes is a chronic (life-long) autoimmune disease that prevents your pancreas from making insulin. It requires daily management with insulin injections and blood sugar monitoring. Both children and adults can be diagnosed with Type 1 diabetes. Even after a lot of research, type 1 diabetes has no cure. Treatment is directed toward managing the amount of sugar in the blood using insulin, diet and lifestyle to prevent complications.

The global Type 1 Diabetes Medicines market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

According to IDF data, in 2022, around 8.75 million people with type 1 diabete. Among them, 1.52 million patients are under 20. People with type 1 diabetes require daily insulin treatment, regular blood glucose monitoring and a healthy lifestyle to manage their condition effectively.

This report studies the global Type 1 Diabetes Medicines demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Type 1 Diabetes Medicines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Type 1 Diabetes Medicines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Type 1 Diabetes Medicines total market, 2019-2030, (USD Million)
Global Type 1 Diabetes Medicines total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Type 1 Diabetes Medicines total market, key domestic companies, and share, (USD Million)
Global Type 1 Diabetes Medicines revenue by player, revenue and market share 2019-2024, (USD Million)
Global Type 1 Diabetes Medicines total market by Type, CAGR, 2019-2030, (USD Million)
Global Type 1 Diabetes Medicines total market by Channel, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Type 1 Diabetes Medicines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Type 1 Diabetes Medicines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Channel. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Type 1 Diabetes Medicines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Type 1 Diabetes Medicines Market, Segmentation by Type
    Insulin
    Others

Global Type 1 Diabetes Medicines Market, Segmentation by Channel:
    Hospital
    Retail Pharmacy

Companies Profiled:
    Novo Nordisk
    Sanofi
    Eli Lilly
    Merck
    AstraZeneca
    Bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Takeda
    Tonghua Dongbao
    United Pharmaceuticals
    Ganli Pharmaceutical
    Biocon
    Wockhardt
    Jiangsu Wanbang
    Geropharm

Key Questions Answered
1. How big is the global Type 1 Diabetes Medicines market?
2. What is the demand of the global Type 1 Diabetes Medicines market?
3. What is the year over year growth of the global Type 1 Diabetes Medicines market?
4. What is the total value of the global Type 1 Diabetes Medicines market?
5. Who are the Major Players in the global Type 1 Diabetes Medicines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Type 1 Diabetes Medicines Introduction
    1.2 World Type 1 Diabetes Medicines Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Type 1 Diabetes Medicines Total Market by Region (by Headquarter Location)
        1.3.1 World Type 1 Diabetes Medicines Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.3 China Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.4 Europe Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.5 Japan Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.6 South Korea Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.7 ASEAN Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
        1.3.8 India Based Company Type 1 Diabetes Medicines Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Type 1 Diabetes Medicines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.2 World Type 1 Diabetes Medicines Consumption Value by Region
        2.2.1 World Type 1 Diabetes Medicines Consumption Value by Region (2019-2024)
        2.2.2 World Type 1 Diabetes Medicines Consumption Value Forecast by Region (2025-2030)
    2.3 United States Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.4 China Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.5 Europe Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.6 Japan Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.7 South Korea Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.8 ASEAN Type 1 Diabetes Medicines Consumption Value (2019-2030)
    2.9 India Type 1 Diabetes Medicines Consumption Value (2019-2030)

3 World Type 1 Diabetes Medicines Companies Competitive Analysis
    3.1 World Type 1 Diabetes Medicines Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Type 1 Diabetes Medicines Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Type 1 Diabetes Medicines in 2023
        3.2.3 Global Concentration Ratios (CR8) for Type 1 Diabetes Medicines in 2023
    3.3 Type 1 Diabetes Medicines Company Evaluation Quadrant
    3.4 Type 1 Diabetes Medicines Market: Overall Company Footprint Analysis
        3.4.1 Type 1 Diabetes Medicines Market: Region Footprint
        3.4.2 Type 1 Diabetes Medicines Market: Company Product Type Footprint
        3.4.3 Type 1 Diabetes Medicines Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Type 1 Diabetes Medicines Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Type 1 Diabetes Medicines Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Type 1 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Type 1 Diabetes Medicines Consumption Value Comparison
        4.2.1 United States VS China: Type 1 Diabetes Medicines Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Type 1 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Type 1 Diabetes Medicines Companies and Market Share, 2019-2024
        4.3.1 United States Based Type 1 Diabetes Medicines Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Type 1 Diabetes Medicines Revenue, (2019-2024)
    4.4 China Based Companies Type 1 Diabetes Medicines Revenue and Market Share, 2019-2024
        4.4.1 China Based Type 1 Diabetes Medicines Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Type 1 Diabetes Medicines Revenue, (2019-2024)
    4.5 Rest of World Based Type 1 Diabetes Medicines Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Type 1 Diabetes Medicines Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Type 1 Diabetes Medicines Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Type 1 Diabetes Medicines Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Insulin
        5.2.2 Others
    5.3 Market Segment by Type
        5.3.1 World Type 1 Diabetes Medicines Market Size by Type (2019-2024)
        5.3.2 World Type 1 Diabetes Medicines Market Size by Type (2025-2030)
        5.3.3 World Type 1 Diabetes Medicines Market Size Market Share by Type (2025-2030)

6 Market Analysis by Channel
    6.1 World Type 1 Diabetes Medicines Market Size Overview by Channel: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Channel
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
    6.3 Market Segment by Channel
        6.3.1 World Type 1 Diabetes Medicines Market Size by Channel (2019-2024)
        6.3.2 World Type 1 Diabetes Medicines Market Size by Channel (2025-2030)
        6.3.3 World Type 1 Diabetes Medicines Market Size Market Share by Channel (2019-2030)

7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Details
        7.1.2 Novo Nordisk Major Business
        7.1.3 Novo Nordisk Type 1 Diabetes Medicines Product and Services
        7.1.4 Novo Nordisk Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Novo Nordisk Recent Developments/Updates
        7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Type 1 Diabetes Medicines Product and Services
        7.2.4 Sanofi Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Type 1 Diabetes Medicines Product and Services
        7.3.4 Eli Lilly Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses
    7.4 Merck
        7.4.1 Merck Details
        7.4.2 Merck Major Business
        7.4.3 Merck Type 1 Diabetes Medicines Product and Services
        7.4.4 Merck Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck Recent Developments/Updates
        7.4.6 Merck Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Type 1 Diabetes Medicines Product and Services
        7.5.4 AstraZeneca Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Bayer
        7.6.1 Bayer Details
        7.6.2 Bayer Major Business
        7.6.3 Bayer Type 1 Diabetes Medicines Product and Services
        7.6.4 Bayer Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Bayer Recent Developments/Updates
        7.6.6 Bayer Competitive Strengths & Weaknesses
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Details
        7.7.2 Boehringer Ingelheim Major Business
        7.7.3 Boehringer Ingelheim Type 1 Diabetes Medicines Product and Services
        7.7.4 Boehringer Ingelheim Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Boehringer Ingelheim Recent Developments/Updates
        7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Details
        7.8.2 Johnson & Johnson Major Business
        7.8.3 Johnson & Johnson Type 1 Diabetes Medicines Product and Services
        7.8.4 Johnson & Johnson Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Johnson & Johnson Recent Developments/Updates
        7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.9 Takeda
        7.9.1 Takeda Details
        7.9.2 Takeda Major Business
        7.9.3 Takeda Type 1 Diabetes Medicines Product and Services
        7.9.4 Takeda Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Takeda Recent Developments/Updates
        7.9.6 Takeda Competitive Strengths & Weaknesses
    7.10 Tonghua Dongbao
        7.10.1 Tonghua Dongbao Details
        7.10.2 Tonghua Dongbao Major Business
        7.10.3 Tonghua Dongbao Type 1 Diabetes Medicines Product and Services
        7.10.4 Tonghua Dongbao Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Tonghua Dongbao Recent Developments/Updates
        7.10.6 Tonghua Dongbao Competitive Strengths & Weaknesses
    7.11 United Pharmaceuticals
        7.11.1 United Pharmaceuticals Details
        7.11.2 United Pharmaceuticals Major Business
        7.11.3 United Pharmaceuticals Type 1 Diabetes Medicines Product and Services
        7.11.4 United Pharmaceuticals Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 United Pharmaceuticals Recent Developments/Updates
        7.11.6 United Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Ganli Pharmaceutical
        7.12.1 Ganli Pharmaceutical Details
        7.12.2 Ganli Pharmaceutical Major Business
        7.12.3 Ganli Pharmaceutical Type 1 Diabetes Medicines Product and Services
        7.12.4 Ganli Pharmaceutical Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Ganli Pharmaceutical Recent Developments/Updates
        7.12.6 Ganli Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Biocon
        7.13.1 Biocon Details
        7.13.2 Biocon Major Business
        7.13.3 Biocon Type 1 Diabetes Medicines Product and Services
        7.13.4 Biocon Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Biocon Recent Developments/Updates
        7.13.6 Biocon Competitive Strengths & Weaknesses
    7.14 Wockhardt
        7.14.1 Wockhardt Details
        7.14.2 Wockhardt Major Business
        7.14.3 Wockhardt Type 1 Diabetes Medicines Product and Services
        7.14.4 Wockhardt Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Wockhardt Recent Developments/Updates
        7.14.6 Wockhardt Competitive Strengths & Weaknesses
    7.15 Jiangsu Wanbang
        7.15.1 Jiangsu Wanbang Details
        7.15.2 Jiangsu Wanbang Major Business
        7.15.3 Jiangsu Wanbang Type 1 Diabetes Medicines Product and Services
        7.15.4 Jiangsu Wanbang Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Jiangsu Wanbang Recent Developments/Updates
        7.15.6 Jiangsu Wanbang Competitive Strengths & Weaknesses
    7.16 Geropharm
        7.16.1 Geropharm Details
        7.16.2 Geropharm Major Business
        7.16.3 Geropharm Type 1 Diabetes Medicines Product and Services
        7.16.4 Geropharm Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Geropharm Recent Developments/Updates
        7.16.6 Geropharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Type 1 Diabetes Medicines Industry Chain
    8.2 Type 1 Diabetes Medicines Upstream Analysis
    8.3 Type 1 Diabetes Medicines Midstream Analysis
    8.4 Type 1 Diabetes Medicines Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Type 1 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Type 1 Diabetes Medicines Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Type 1 Diabetes Medicines Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Type 1 Diabetes Medicines Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Type 1 Diabetes Medicines Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Type 1 Diabetes Medicines Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Type 1 Diabetes Medicines Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Type 1 Diabetes Medicines Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Type 1 Diabetes Medicines Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Type 1 Diabetes Medicines Players in 2023
 Table 12. World Type 1 Diabetes Medicines Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Type 1 Diabetes Medicines Company Evaluation Quadrant
 Table 14. Head Office of Key Type 1 Diabetes Medicines Players
 Table 15. Type 1 Diabetes Medicines Market: Company Product Type Footprint
 Table 16. Type 1 Diabetes Medicines Market: Company Product Application Footprint
 Table 17. Type 1 Diabetes Medicines Mergers & Acquisitions Activity
 Table 18. United States VS China Type 1 Diabetes Medicines Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Type 1 Diabetes Medicines Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Type 1 Diabetes Medicines Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Type 1 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Type 1 Diabetes Medicines Revenue Market Share (2019-2024)
 Table 23. China Based Type 1 Diabetes Medicines Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Type 1 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Type 1 Diabetes Medicines Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Type 1 Diabetes Medicines Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Type 1 Diabetes Medicines Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Type 1 Diabetes Medicines Revenue Market Share (2019-2024)
 Table 29. World Type 1 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Type 1 Diabetes Medicines Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Type 1 Diabetes Medicines Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Type 1 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
 Table 33. World Type 1 Diabetes Medicines Market Size by Channel (2019-2024) & (USD Million)
 Table 34. World Type 1 Diabetes Medicines Market Size by Channel (2025-2030) & (USD Million)
 Table 35. Novo Nordisk Basic Information, Manufacturing Base and Competitors
 Table 36. Novo Nordisk Major Business
 Table 37. Novo Nordisk Type 1 Diabetes Medicines Product and Services
 Table 38. Novo Nordisk Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Novo Nordisk Recent Developments/Updates
 Table 40. Novo Nordisk Competitive Strengths & Weaknesses
 Table 41. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 42. Sanofi Major Business
 Table 43. Sanofi Type 1 Diabetes Medicines Product and Services
 Table 44. Sanofi Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Sanofi Recent Developments/Updates
 Table 46. Sanofi Competitive Strengths & Weaknesses
 Table 47. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 48. Eli Lilly Major Business
 Table 49. Eli Lilly Type 1 Diabetes Medicines Product and Services
 Table 50. Eli Lilly Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Eli Lilly Recent Developments/Updates
 Table 52. Eli Lilly Competitive Strengths & Weaknesses
 Table 53. Merck Basic Information, Manufacturing Base and Competitors
 Table 54. Merck Major Business
 Table 55. Merck Type 1 Diabetes Medicines Product and Services
 Table 56. Merck Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Merck Recent Developments/Updates
 Table 58. Merck Competitive Strengths & Weaknesses
 Table 59. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 60. AstraZeneca Major Business
 Table 61. AstraZeneca Type 1 Diabetes Medicines Product and Services
 Table 62. AstraZeneca Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. AstraZeneca Recent Developments/Updates
 Table 64. AstraZeneca Competitive Strengths & Weaknesses
 Table 65. Bayer Basic Information, Manufacturing Base and Competitors
 Table 66. Bayer Major Business
 Table 67. Bayer Type 1 Diabetes Medicines Product and Services
 Table 68. Bayer Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Bayer Recent Developments/Updates
 Table 70. Bayer Competitive Strengths & Weaknesses
 Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
 Table 72. Boehringer Ingelheim Major Business
 Table 73. Boehringer Ingelheim Type 1 Diabetes Medicines Product and Services
 Table 74. Boehringer Ingelheim Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Boehringer Ingelheim Recent Developments/Updates
 Table 76. Boehringer Ingelheim Competitive Strengths & Weaknesses
 Table 77. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
 Table 78. Johnson & Johnson Major Business
 Table 79. Johnson & Johnson Type 1 Diabetes Medicines Product and Services
 Table 80. Johnson & Johnson Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Johnson & Johnson Recent Developments/Updates
 Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
 Table 83. Takeda Basic Information, Manufacturing Base and Competitors
 Table 84. Takeda Major Business
 Table 85. Takeda Type 1 Diabetes Medicines Product and Services
 Table 86. Takeda Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Takeda Recent Developments/Updates
 Table 88. Takeda Competitive Strengths & Weaknesses
 Table 89. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
 Table 90. Tonghua Dongbao Major Business
 Table 91. Tonghua Dongbao Type 1 Diabetes Medicines Product and Services
 Table 92. Tonghua Dongbao Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Tonghua Dongbao Recent Developments/Updates
 Table 94. Tonghua Dongbao Competitive Strengths & Weaknesses
 Table 95. United Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 96. United Pharmaceuticals Major Business
 Table 97. United Pharmaceuticals Type 1 Diabetes Medicines Product and Services
 Table 98. United Pharmaceuticals Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. United Pharmaceuticals Recent Developments/Updates
 Table 100. United Pharmaceuticals Competitive Strengths & Weaknesses
 Table 101. Ganli Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 102. Ganli Pharmaceutical Major Business
 Table 103. Ganli Pharmaceutical Type 1 Diabetes Medicines Product and Services
 Table 104. Ganli Pharmaceutical Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Ganli Pharmaceutical Recent Developments/Updates
 Table 106. Ganli Pharmaceutical Competitive Strengths & Weaknesses
 Table 107. Biocon Basic Information, Manufacturing Base and Competitors
 Table 108. Biocon Major Business
 Table 109. Biocon Type 1 Diabetes Medicines Product and Services
 Table 110. Biocon Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Biocon Recent Developments/Updates
 Table 112. Biocon Competitive Strengths & Weaknesses
 Table 113. Wockhardt Basic Information, Manufacturing Base and Competitors
 Table 114. Wockhardt Major Business
 Table 115. Wockhardt Type 1 Diabetes Medicines Product and Services
 Table 116. Wockhardt Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Wockhardt Recent Developments/Updates
 Table 118. Wockhardt Competitive Strengths & Weaknesses
 Table 119. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
 Table 120. Jiangsu Wanbang Major Business
 Table 121. Jiangsu Wanbang Type 1 Diabetes Medicines Product and Services
 Table 122. Jiangsu Wanbang Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Jiangsu Wanbang Recent Developments/Updates
 Table 124. Jiangsu Wanbang Competitive Strengths & Weaknesses
 Table 125. Geropharm Basic Information, Manufacturing Base and Competitors
 Table 126. Geropharm Major Business
 Table 127. Geropharm Type 1 Diabetes Medicines Product and Services
 Table 128. Geropharm Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Geropharm Recent Developments/Updates
 Table 130. Geropharm Competitive Strengths & Weaknesses
 Table 131. Global Key Players of Type 1 Diabetes Medicines Upstream (Raw Materials)
 Table 132. Global Type 1 Diabetes Medicines Typical Customers


List of Figures
 Figure 1. Type 1 Diabetes Medicines Picture
 Figure 2. World Type 1 Diabetes Medicines Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Type 1 Diabetes Medicines Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Type 1 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Type 1 Diabetes Medicines Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Type 1 Diabetes Medicines Revenue (2019-2030) & (USD Million)
 Figure 13. Type 1 Diabetes Medicines Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Type 1 Diabetes Medicines Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Type 1 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Type 1 Diabetes Medicines by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Type 1 Diabetes Medicines Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Type 1 Diabetes Medicines Markets in 2023
 Figure 27. United States VS China: Type 1 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Type 1 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Type 1 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Type 1 Diabetes Medicines Market Size Market Share by Type in 2023
 Figure 31. Insulin
 Figure 32. Others
 Figure 33. World Type 1 Diabetes Medicines Market Size Market Share by Type (2019-2030)
 Figure 34. World Type 1 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Type 1 Diabetes Medicines Market Size Market Share by Channel in 2023
 Figure 36. Hospital
 Figure 37. Retail Pharmacy
 Figure 38. World Type 1 Diabetes Medicines Market Size Market Share by Channel (2019-2030)
 Figure 39. Type 1 Diabetes Medicines Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
Bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Wockhardt
Jiangsu Wanbang
Geropharm